Mylan announces $500M share repurchase program Mylan announced that its Board of Directors has approved the repurchase of up to $500M of the company's common stock in the open market or through other methods.
News For MYL From The Last 14 Days
Check below for free stories on MYL the last two weeks.
Mylan, Novartis may consider bidding for Boehringer unit, Reuters reports Bank of America Merrill Lynch (BAC) has been selected by Boehringer Ingelheim's Ben Venue Laboratories to explore a potential sale of its Bedford Laboratories generic sterile injectable drugs business, Reuters reports. Mylan (MYL), Novartis (NVS) and Pfizer (PFE) may consider bidding for the business, according to sources. Reference Link